Current Issue Subscriptions
Back Issues Advertising
More Information Classified Ads
For Authors Continuing Education
 
Vol. 75, No. 9		  
ISSN: 1488-2159		  
November 2009

 

Management of Frey Syndrome Using Botulinum Neurotoxin: A Case Report

FULL TEXT

• Samson Ng, BSc (Pharm), MSc, DMD, FRCD(C), FDSRCSEd, Dip ABOMP, Dip ABOM •
• Cathy Torjek, CDA •
• Allan Hovan, DMD, MSD, FRCD(C), Dip ABOM •

A b s t r a c t

Frey syndrome is manifested clinically by hemifacial flushing and sweating after a gustatory stimulus. Frey syndrome is usually secondary to traumatic injury in the parotid region and is thought to be the result of misdirected re-sprouting of damaged autonomic nerve fibres. In this case report, we highlight the clinical and psychosocial aspects of Frey syndrome from a patient's perspective, outline the pathophysiology of the condition and current management strategies, and describe the use of botulinum neurotoxin in the treatment of Frey syndrome.

 


 
Reply to this article | View replies [0]

Full text provided in PDF format


 

Mission Statement & Editor's Message | Multimedia Centre | Readership Survey
Contact the Editor | Français

www.cda-adc.ca